Phases I-II Matched Case-Control Study of Human Fetal Liver Cell Transplantation for Treatment of Chronic Liver Disease

Phases I-II Matched Case-Control Study of Human Fetal Liver Cell Transplantation for Treatment of Chronic Liver Disease

Fetal hepatocytes have a high regenerative capacity. The aim of the study was to assess treatment safety and clinical efficacy of human fetal liver cell transplantation through splenic artery infusion. Patients with endstage chronic liver disease on the waiting list for liver transplantation were en...

Full description

Bibliographic Details
Main Authors: Giada Pietrosi M.D., Giovanni Vizzini, Jorg Gerlach, Cinzia Chinnici, Angelo Luca, Giandomenico Amico, Monica D'amato, Pier Giulio Conaldi, Sergio Li Petri, Marco Spada, Fabio Tuzzolino, Luigi Alio, Eva Schmelzer, Bruno Gridelli
Format: Article
Language:English
Published: SAGE Publishing 2015-08-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368914X682422

Internet

https://doi.org/10.3727/096368914X682422

Similar Items